ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
3,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
3,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
6,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
7,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
8,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
9,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9,5,Multi-organ disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
11,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
12,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
13,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
14,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
14,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
16,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
16,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
17,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
17,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
17,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
18,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
19,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
20,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
20,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
21,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
21,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
22,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
23,2,Myopathy,Myopathies,Muscle disorders,Musc,N
24,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
24,2,Myopathy,Myopathies,Muscle disorders,Musc,N
25,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
26,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
27,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
27,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
27,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
29,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
29,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,1,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
31,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
32,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
33,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
34,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
34,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
35,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
37,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
37,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
39,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
39,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
39,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
40,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
41,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
43,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
44,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
44,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
45,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
46,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
46,3,Ventricular failure,Heart failures NEC,Heart failures,Card,N
47,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
47,3,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,N
48,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
48,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,4,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
49,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
49,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
49,6,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
49,7,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
49,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,10,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
49,11,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
49,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,13,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,15,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
50,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
51,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
51,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
52,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
53,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
54,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
55,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
55,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
55,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
55,4,Myopathy,Myopathies,Muscle disorders,Musc,N
55,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
55,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
55,7,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
57,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
58,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
59,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
59,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
60,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
60,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
61,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,2,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
61,3,Venous occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
62,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
63,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
64,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
64,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
64,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
64,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
64,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
65,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
67,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
67,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
68,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
68,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
68,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
69,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
69,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
69,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
70,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
70,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
70,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
70,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
70,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
70,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
71,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
71,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
71,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
71,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
71,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
71,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
72,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
72,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
74,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
74,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
75,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
75,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
76,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
77,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
78,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
78,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
79,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
79,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
79,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
79,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
82,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
83,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
83,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
83,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
83,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
84,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
85,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
85,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
85,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
87,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
88,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
89,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
89,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
89,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
89,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
89,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
90,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
90,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
92,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
92,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
92,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
93,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
93,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
94,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
95,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
95,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
96,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
97,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
97,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
98,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
98,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
98,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
98,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
99,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
99,2,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
99,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
99,4,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
99,5,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
100,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,3,Human rhinovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
100,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,5,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
101,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
102,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
102,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
102,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
102,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
102,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
102,7,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
102,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
102,9,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,10,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,11,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
102,12,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
102,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
102,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
102,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
102,17,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
102,18,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
102,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
102,20,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
103,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
104,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
104,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
105,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
106,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
108,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
109,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
109,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
110,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
110,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
110,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
112,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
113,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
114,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
114,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
114,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
115,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
115,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
115,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
115,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
115,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
115,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
116,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
116,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
117,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
117,2,Pulmonary function test,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
118,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
118,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
119,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
119,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
120,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
120,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
120,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
123,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
123,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
124,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
124,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
124,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
124,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
124,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
125,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
125,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
126,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
126,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
126,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
127,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,2,Lymph node palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
127,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
127,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
128,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
129,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
129,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
129,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
129,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
129,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
129,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
129,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
129,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
130,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
131,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
132,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
133,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
134,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
134,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
134,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
134,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
134,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
134,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
135,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
135,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
135,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
135,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
135,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
135,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
136,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
136,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
136,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
137,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
138,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
139,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
139,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
140,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
140,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
141,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
142,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
142,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
142,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
142,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
142,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,7,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
142,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
142,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
142,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
142,13,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
143,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
144,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
145,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
146,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
147,1,External ear neoplasm malignant,Aural neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
147,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,4,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,5,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,7,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,8,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
147,9,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
148,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
149,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
149,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
150,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
151,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
151,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
152,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
153,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
153,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
154,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
154,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
154,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
154,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
154,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
157,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
157,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
157,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
158,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
158,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
158,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
158,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
158,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
158,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
159,1,Granulomatous lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
159,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
159,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
159,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
159,5,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
159,6,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
159,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,1,Neuroendocrine carcinoma,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
161,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
161,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
161,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
162,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
162,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
163,2,Headache,Headaches NEC,Headaches,Nerv,N
163,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
163,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
164,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
164,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
164,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
165,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
166,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
166,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
166,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
166,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
166,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
166,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
166,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
167,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
167,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
167,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
168,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
168,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
168,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
168,4,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
168,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
169,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
169,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
169,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
170,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
171,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
171,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
171,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
172,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
172,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
173,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
173,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
174,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
174,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
175,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
175,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
176,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
176,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
177,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
177,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
178,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
178,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
179,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
179,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
180,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
180,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
180,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
180,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,5,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
180,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
181,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
182,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
183,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
184,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
185,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
185,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
185,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
186,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
187,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
188,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
189,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
189,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
189,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
189,4,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
189,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
189,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
190,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
190,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
190,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
190,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
190,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
190,6,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
191,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
191,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
191,3,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
191,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
191,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
192,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
193,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
194,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
195,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
196,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
197,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
198,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
199,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
200,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
202,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
203,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
204,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
204,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
204,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
205,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
206,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
207,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
208,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
208,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
208,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
208,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
208,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
208,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
209,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
210,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
210,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
210,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
210,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
210,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
210,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
211,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
211,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
211,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
211,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
212,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
212,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
213,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
214,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,Y
214,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
214,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
214,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
214,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
214,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
215,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
216,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
217,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
218,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
219,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
220,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
222,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
223,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
226,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
226,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
227,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
227,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
227,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
227,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
228,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
229,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
229,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
230,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
231,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
232,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
234,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
234,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
235,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
236,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
236,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
238,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
239,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
242,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
243,2,Follicular lymphoma stage IV,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
243,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
243,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
243,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
243,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
244,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
245,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
245,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
246,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
247,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
247,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
247,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
248,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
249,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
251,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
252,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
253,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
255,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
256,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
256,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
256,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
256,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
257,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
258,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
259,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
259,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,3,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
260,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
261,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
262,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
263,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
263,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
264,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
265,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
268,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
269,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
269,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
270,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
271,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
272,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
272,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
273,1,Hodgkin's disease recurrent,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
274,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
274,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
274,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
275,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
276,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
277,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
277,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
278,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
278,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
